STERIS ROE 2010-2024 | STE

Current and historical return on equity (ROE) values for STERIS (STE) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
STERIS ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-09-30 $0.44B $6.61B 6.76%
2024-06-30 $0.40B $6.37B 6.32%
2024-03-31 $0.38B $6.32B 6.04%
2023-12-31 $0.57B $6.43B 9.12%
2023-09-30 $0.55B $6.19B 8.98%
2023-06-30 $0.12B $6.18B 1.99%
2023-03-31 $0.11B $6.09B 1.76%
2022-12-31 $-0.03B $6.05B -0.45%
2022-09-30 $-0.01B $5.81B -0.13%
2022-06-30 $0.38B $6.42B 5.77%
2022-03-31 $0.24B $6.55B 3.71%
2021-12-31 $0.28B $6.62B 4.72%
2021-09-30 $0.25B $6.55B 4.78%
2021-06-30 $0.29B $6.59B 6.35%
2021-03-31 $0.40B $3.89B 10.67%
2020-12-31 $0.43B $3.88B 12.02%
2020-09-30 $0.42B $3.66B 12.14%
2020-06-30 $0.41B $3.49B 12.20%
2020-03-31 $0.41B $3.42B 12.27%
2019-12-31 $0.39B $3.40B 12.03%
2019-09-30 $0.34B $3.24B 10.52%
2019-06-30 $0.32B $3.25B 10.04%
2019-03-31 $0.30B $3.19B 9.68%
2018-12-31 $0.27B $3.11B 8.57%
2018-09-30 $0.32B $3.13B 10.06%
2018-06-30 $0.30B $3.10B 9.72%
2018-03-31 $0.29B $3.22B 9.45%
2017-12-31 $0.24B $3.12B 8.16%
2017-09-30 $0.14B $3.04B 4.95%
2017-06-30 $0.12B $2.94B 4.13%
2017-03-31 $0.11B $2.81B 3.75%
2016-12-31 $0.14B $2.77B 4.75%
2016-09-30 $0.17B $3.01B 5.49%
2016-06-30 $0.14B $3.05B 5.31%
2016-03-31 $0.11B $3.04B 5.40%
2015-12-31 $0.09B $2.99B 6.01%
2015-09-30 $0.11B $1.09B 10.32%
2015-06-30 $0.13B $1.10B 12.41%
2015-03-31 $0.14B $1.07B 12.61%
2014-12-31 $0.13B $1.08B 12.51%
2014-09-30 $0.12B $1.07B 11.85%
2014-06-30 $0.12B $1.07B 11.98%
2014-03-31 $0.13B $1.04B 12.96%
2013-12-31 $0.13B $1.01B 13.47%
2013-09-30 $0.15B $0.99B 15.77%
2013-06-30 $0.16B $0.97B 17.31%
2013-03-31 $0.16B $0.95B 17.76%
2012-12-31 $0.16B $0.92B 18.74%
2012-09-30 $0.15B $0.88B 17.84%
2012-06-30 $0.14B $0.83B 17.18%
2012-03-31 $0.14B $0.82B 17.15%
2011-12-31 $0.13B $0.78B 16.70%
2011-09-30 $0.12B $0.78B 15.32%
2011-06-30 $0.13B $0.82B 16.33%
2011-03-31 $0.05B $0.79B 7.01%
2010-12-31 $0.04B $0.75B 5.87%
2010-09-30 $0.06B $0.73B 8.51%
2010-06-30 $0.06B $0.70B 7.77%
2010-03-31 $0.13B $0.75B 16.91%
2009-12-31 $0.13B $0.73B 16.84%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $21.780B $5.139B
STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $228.640B 27.34
Intuitive Surgical (ISRG) United States $203.692B 93.44
Alcon (ALC) Switzerland $44.930B 30.06
Edwards Lifesciences (EW) United States $42.731B 27.14
IQVIA Holdings (IQV) United States $36.547B 20.14
IDEXX Laboratories (IDXX) United States $34.559B 40.70
DexCom (DXCM) United States $33.915B 51.08
Mettler-Toledo (MTD) United States $28.793B 35.76
Waters (WAT) United States $24.670B 36.48
SONOVA HOLDING (SONVY) Switzerland $20.792B 0.00
Hologic (HOLX) United States $16.284B 17.68
Fresenius Medical Care AG KGaA (FMS) Germany $14.594B 14.98
Globus Medical (GMED) United States $12.625B 31.97
Sysmex ADR (SSMXY) Japan $12.004B 0.00
Penumbra (PEN) United States $10.246B 100.36
Masimo (MASI) United States $9.328B 45.14
Glaukos (GKOS) United States $8.626B 0.00
Teleflex (TFX) United States $8.371B 13.35
Integer Holdings (ITGR) United States $4.770B 27.04
Inari Medical (NARI) United States $4.664B 0.00
PROCEPT BioRobotics (PRCT) United States $3.783B 0.00
Veracyte (VCYT) United States $3.525B 105.77
LivaNova (LIVN) United Kingdom $2.712B 15.66
Nihon Kohden (NHNKY) Japan $2.552B 19.39
Tandem Diabetes Care (TNDM) United States $2.434B 0.00
TransMedics (TMDX) United States $2.267B 71.86
Elekta AB (EKTAY) Sweden $2.252B 20.24
Integra LifeSciences Holdings (IART) United States $2.014B 10.52
Alphatec Holdings (ATEC) United States $1.672B 0.00
RxSight (RXST) United States $1.365B 0.00
Artivion (AORT) United States $1.298B 86.00
Pulse Biosciences (PLSE) United States $1.288B 0.00
Paragon 28 (FNA) United States $1.090B 0.00
OPKO Health (OPK) United States $1.037B 0.00
AxoGen (AXGN) United States $0.801B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.791B 13.45
IRadimed (IRMD) United States $0.750B 40.56
Mesa Laboratories (MLAB) United States $0.748B 17.63
SiBone (SIBN) United States $0.703B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.700B 0.00
Treace Medical Concepts (TMCI) United States $0.626B 0.00
OrthoPediatrics (KIDS) United States $0.581B 0.00
Delcath Systems (DCTH) United States $0.499B 0.00
ClearPoint Neuro (CLPT) United States $0.482B 0.00
Semler Scientific (SMLR) United States $0.482B 25.35
AngioDynamics (ANGO) United States $0.462B 0.00
Pacific Biosciences Of California (PACB) United States $0.422B 0.00
Tactile Systems Technology (TCMD) United States $0.420B 22.74
NeuroPace (NPCE) United States $0.411B 0.00
CVRx (CVRX) United States $0.388B 0.00
Inogen (INGN) United States $0.278B 0.00
Alpha Tau Medical (DRTS) Israel $0.259B 0.00
Accuray (ARAY) United States $0.224B 0.00
Anteris Technologies Global (AVR) Australia $0.223B 0.00
KORU Medical Systems (KRMD) United States $0.201B 0.00
Nevro (NVRO) United States $0.190B 0.00
Sight Sciences (SGHT) United States $0.142B 0.00
Sensus Healthcare (SRTS) United States $0.135B 14.45
LENSAR (LNSR) United States $0.129B 0.00
Atossa Genetics (ATOS) United States $0.106B 0.00
Spectral Diagnostics (EDTXF) Canada $0.105B 0.00
Neuronetics (STIM) United States $0.094B 0.00
Monogram Orthopaedics (MGRM) United States $0.094B 0.00
EDAP TMS S.A (EDAP) France $0.091B 0.00
908 Devices (MASS) United States $0.087B 0.00
Hyperfine (HYPR) United States $0.080B 0.00
Vicarious Surgical (RBOT) United States $0.079B 0.00
Rapid Micro Biosystems (RPID) United States $0.077B 0.00
InspireMD (NSPR) Israel $0.067B 0.00
EnVVeno Medical (NVNO) United States $0.058B 0.00
Lucid Diagnostics (LUCD) United States $0.057B 0.00
Covalon Technologies (CVALF) Canada $0.056B 29.43
Positron (POSC) United States $0.052B 0.00
Baird Medical Investment Holdings (BDMD) $0.047B 0.00
Microbot Medical (MBOT) United States $0.037B 0.00
Spectral AI (MDAI) United States $0.036B 0.00
Accelerate Diagnostics (AXDX) United States $0.034B 0.00
Envoy Medical (COCH) United States $0.034B 0.00
WORK Medical Technology Group (WOK) China $0.033B 0.00
Precision Optics (POCI) United States $0.033B 0.00
NexGel (NXGL) United States $0.026B 0.00
Helius Medical Technologies (HSDT) United States $0.025B 0.00
DarioHealth (DRIO) United States $0.021B 0.00
Adagio Medical Holdings (ADGM) United States $0.018B 0.00
Biosig Technologies (BSGM) United States $0.018B 0.00
Ekso Bionics Holdings (EKSO) United States $0.012B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.011B 0.00
PAVmed (PAVM) United States $0.007B 0.00
Aspira Women's Health (AWH) United States $0.006B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Tenon Medical (TNON) United States $0.005B 0.00
T2 Biosystems (TTOO) United States $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00